ReviewMolecular biology reports2026
Recent advances in the detection and functional analysis of circRNAs with short-read RNA sequencing-based methods.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular RNAs (circRNAs) were first identified approximately 50 years ago in pathogenic viroids as single-stranded, covalently closed RNA molecules. Initially considered by-products of splicing, circRNAs are now recognised as an important class of regulatory RNAs involved in microRNA sponging, RNA-protein interactions, and cellular pathways. Their closed-loop structure, generated through backsplicing, confers resistance to exonucleolytic degradation and contributes to their stability. Owing to their tissue- and disease-specific expression, circRNAs have emerged as promising biomarkers for cancer, neurodegenerative disorders, and cardiovascular disease. Over the past decade, numerous bioinformatics tools utilising RNA-sequencing (RNA-seq) data have been developed for circRNA detection and analysis. Detection methods have evolved from manual split-read inspection to automated identification of the back spliced junction, while annotation pipelines now resolve the genomic origins and structural characteristics of circRNAs. Because individual circRNA callers vary considerably in sensitivity and specificity, a combined usage of tools in circRNA detection has become the preferred strategy for generating high-confidence datasets. Beyond their non-coding functions, increasing evidence suggests that some circRNAs possess protein-coding potential through open reading frames, cap-independent translation mechanisms, internal ribosome entry sites (IRESs), and N6-methyladenosine modifications. A new generation of bioinformatic tools can now assess the protein-coding potential of circRNAs, integrating the above features, as well as machine learning and deep learning approaches refining these predictions. This review summarises recently developed short-read RNA-seq bioinformatics tools for circRNA detection, consensus calling, annotation, and protein-coding potential prediction, with a particular focus on advances from the past five years that facilitate the identification of translatable circRNAs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.